M-M-R II vaccine is named as a drug or biological intervention in 2 clinical trials in our USA trial register, none of which are currently recruiting. Lead sponsors include Sanofi (1) and Sanofi Pasteur, a Sanofi Company (1). Registered phase: Phase 3. Conditions studied include Pneumococcal Immunization.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06736041 | Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (ClinicalTrials.gov ↗) Pneumococcal Immunization |
Phase 3 | Active, closed |
| NCT06824181 | Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (ClinicalTrials.gov ↗) Pneumococcal Immunization |
Phase 3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Pneumococcal Immunization | 2 |
| Lead sponsor | Trials |
|---|---|
| Sanofi | 1 |
| Sanofi Pasteur, a Sanofi Company | 1 |
| Register | M-M-R II vaccine trials |
|---|---|
| Clinical trials in USA | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how M-M-R II vaccine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists M-M-R II vaccine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.